Skip to content
Catalyst

pregnenoloneFinding

Pregnenolone increases depression remission rate

raisesVery limited evidenceFinding

01 · The sentence it was drawn from

“Depression remission rates were greater in the pregnenolone group (61%) compared with the placebo group (37%), as assessed by the IDS-SR (χ(2)(1)=3.99, p=0.046), but not the HRSD.”
Quoted verbatim from A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression.
This finding among the 3 findings on its endpoint

pregnenolone

Depression remission rate

raises

Who
Adults with bipolar disorder in a depressed mood state, pregnenolone or placebo added to ongoing therapy for 12 weeks; remission as assessed by the Inventory of Depressive Symptomatology-Self-Report (IDS-SR), not by the HRSD
Dose studied
pregnenolone titrated to 500 mg/day, add-on therapy

Very limited evidencePMID 24917198 · 2014

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GDK1AVEPQNTF2WNPXBD95T